<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112121">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643681</url>
  </required_header>
  <id_info>
    <org_study_id>KSC-MSCs-LIDD</org_study_id>
    <nct_id>NCT01643681</nct_id>
  </id_info>
  <brief_title>Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration</brief_title>
  <official_title>Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biostar</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Biostar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy and safety of autologous
      transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with
      lumbar intervertebral disc degeneration.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Magnetic Resonance Imaging</measure>
    <time_frame>24 weeks</time_frame>
    <description>To evaluate the change of treated lumbar intervertebral discs using Magnetic Resonance Imaging (MRI) at 6 months post injection of MSCs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of Neurological Functions</measure>
    <time_frame>24 weeks</time_frame>
    <description>To evaluate the change of treated lumbar intervertebral discs using Muscle Test, Somatosensory Test, Deep Tendon Reflex and VAS (Visual Analogue Scale Score 0-10) at 6 months post injection of MSCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety evaluation</measure>
    <time_frame>24 weeks</time_frame>
    <description>To determine the overall safety of Autologous Adipose Tissue Derived Mesenchymal Stem Cells carrier using physical examinations, vital signs, treatment emergent adverse events (TEAEs), and the results of clinical lab tests.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Lumbar Intervertebral Disc Degeneration</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous Adipose Tissue derived MSCs Transplantation</intervention_name>
    <description>Into lumbar intervertebral disc infusion of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 4x10e7 cells/1mL</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who understand and sign the consent form for this study

          -  Age :19-70, males and females

          -  Have chronic low back pain for at least 1 year

          -  Have failed 1 year of non-operative low back pain management

          -  Have degenerated intervertebral disc on T2-weighted MR images

          -  confirmed by positive discography

          -  Have significant lumbar instability at degenerated intervertebral disc

        Exclusion Criteria:

          -  Have significant lumbar herniated intervertebral disc

          -  Women who are pregnant or breast feeding or planning to become pregnant during the
             study

          -  History or current evidence of alcohol or drug abuse or is a recreational user of
             illicit drugs or prescription medications

          -  Serious pre-existing medical conditions like Cardiovascular Diseases, Renal Diseases,
             Liver Diseases, Endocrine Diseases, Cancer and Diabetes Mellitus

          -  Participation in another clinical trial or treatment with a different investigational
             product within 30 days prior to inclusion in the study

          -  Other pathologic conditions or circumstances that difficult participation in the
             study according to medical criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tai-Hyoung Cho, M.D. &amp; Ph.D.</last_name>
    <phone>82-10-3791-5338</phone>
    <email>choth2@korea.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tai-Hyoung Cho, M.D. &amp; Ph.D.</last_name>
      <phone>82-10-3791-5338</phone>
      <email>choth2@korea.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Tai-Hyoung Cho, M.D. &amp; Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dong-Hyuk Park, M.D. &amp; Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jang-Bo Lee, M.D. &amp; Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sang-Heon Lee, M.D. &amp; Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 24, 2014</lastchanged_date>
  <firstreceived_date>July 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
